Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease

Abstract

The 2015 Santa Fe Bone Symposium was a venue for healthcare professionals and clinical researchers to present and discuss the clinical relevance of recent advances in the science of skeletal disorders, with a focus on osteoporosis and metabolic bone disease. Symposium topics included new developments in the translation of basic bone science to improved patient care, osteoporosis treatment duration, pediatric bone disease, update of fracture risk assessment, cancer treatment-related bone loss, fracture liaison services, a review of the most significant studies of the past year, and the use of telementoring with Bone Health Extension for Community Healthcare Outcomes, a force multiplier to improve the care of osteoporosis in underserved communities.

Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases

“…These virtual communities of practice provide opportunities to improve clinical skills so that patients can receive better care, closer to home, with greater convenience, and lower cost than referral to a specialty center that may be located far from the patient who needs the care ( 144 ). Progress with Bone Health ECHO programs has been reported at previous SFBS ( 10 – 16 ) and updated here.…”

Determinants of imminent fracture risk in postmenopausal women with osteoporosis

“…Prior fracture is a key risk factor for subsequent fracture [9][10][11]. Fracture risk is also known to increase with advancing age, low bone mineral density (BMD), and greater risk or history of falls [12,13]. Certain pharmacologic therapies, such as glucocorticoids, and medical conditions increase the risk of secondary osteoporosis and related fractures through their direct impact on bone density or structure [14][15][16][17].…”